Evaluation of profits in the ethical drug industry

Evaluation of profits in the ethical drug industry

Thesis (M.B.A.)--Boston University

Bibliographic Details
Main Author:	Geyer, Gerherd
Language:	en_US
Published:	Boston University 2018
Subjects:	Pharmaceuticals Drug industry Ethics Medicine
Online Access:	https://hdl.handle.net/2144/31365

Similar Items

Non-profit drug research and development: the case study of Genethon
by: Szymon Jarosławski, et al.
Published: (2019-01-01)

Business Ethics and CSR in Pharmaceutical Industry in the Czech Republic and Hungary?
by: Markéta Lőrinczy, et al.
Published: (2015-01-01)

The Shared Ethical Responsibility of Medically and Non-medically Qualified Experts in Human Drug Development Teams
by: Sandor Kerpel-Fronius, et al.
Published: (2018-09-01)

ETHICAL ASPECTS OF THE COOPERATION BETWEEN PHYSICIAN AND PHARMACEUTICAL INDUSTRY
by: Jože Drinovec, et al.
Published: (2001-09-01)

Influence of pharmaceutical advertising on consumers: an exploratory descriptive study
by: Knoesen, Brent Claud
Published: (2007)

Controversial advertising of medicines. A comparison between Poland and the United States
by: Marta Makowska
Published: (2018-07-01)

Evolution of Ethical Principles in the Practice of Pharmaceutical Medicine From a UK Perspective
by: Thomas Morris, et al.
Published: (2020-01-01)

Research Ethics and Commercial Drug Development: When Integrity Threatens Profitability
by: Bélisle Pipon, Jean-Christophe
Published: (2016-05-01)

ANALYSIS OF INDUSTRIAL PRACTICE OF DRUG QUALITY RISK MANAGEMENT IN RUSSIAN PHARMACEUTICAL ENTERPRISES
by: A. B. Kashirina, et al.
Published: (2021-03-01)

The ethical advantages of video conferencing in medical education
by: Joshua M. Kruger, et al.
Published: (2020-01-01)

Marketing research of the national antiarrhythmic drugs market
by: T. P. Zarichna, et al.
Published: (2019-08-01)

Comparison of two granulation processes with the view to reduce manufacturing cost
by: Maclean, Aldritt Allister
Published: (2004)

TOO MUCH DRUG ADVERTISING? A QUALITATIVE PERSPECTIVE OF ROMANIAN PHARMACEUTICAL MARKET
by: Ana Valentina Ruse, et al.
Published: (2018-07-01)

Analysis of the importance of drug packaging quality for end users and pharmaceutical industry as a part of the quality management system
by: Lončar Irma M., et al.
Published: (2013-01-01)

The impact of promotional strategies of pharmaceutical companies on doctor’s recommendation of branded drugs: an empirical study on pharmaceutical industry in Sri Lanka
by: M. M. T. Punchibandara
Published: (2018-03-01)

Evaluation of the effectiveness of state regulation of the pharmaceutical industry in Russia
by: Natalia S. Klunko
Published: (2019-07-01)

Participants’ awareness of ethical compliance, safety and protection during participation in pharmaceutical industry clinical trials: a controlled survey
by: Gerardo González-Saldivar, et al.
Published: (2019-01-01)

Nanofibres in Drug Delivery
by: Williams, Gareth R.
Published: (2018)

Nanofibres in Drug Delivery
Published: (2018)

Profitability Determinants in Indian Drugs and Pharmaceutical Industry: An Analysis of Pre and Post TRIPS Period
by: Shilpi TYAGI, et al.
Published: (2016-05-01)

The strategy of promoting and selling medicines on the Romanian market
by: Elena GURGU, et al.
Published: (2019-12-01)

Public Health Ethics: Cases Spanning the Globe
Published: (2016)

Direct-To-Consumer Advertising of Prescription Drugs : An Ethical Assessment
by: Chini, Farrah
Published: (2011)

Teaching and Learning Pharmaceutical Code of Ethics as a Syllabus
by: A Shafiee, et al.
Published: (2008-06-01)

Teaching and Learning Pharmaceutical Code of Ethics as a Syllabus
by: A Shafiee, et al.
Published: (2008-03-01)

A study of the motivational value of sales contests in the pharmaceutical industry /
by: Howard, Cecil Gerald
Published: (1965)

Multilayer network analysis of the drugs development cycle in the global pharmaceutical industry
by: Hiromitsu Goto, et al.
Published: (2020-11-01)

Drug ingredient acquisition cost determination for third-party prescription drug programs /
by: Wadelin, Jeffrey W.
Published: (1986)

Branded prescription drug spending: a framework to evaluate policy options
by: Jeromie Ballreich, et al.
Published: (2017-10-01)

Reimportation of Prescription Drugs as Contributing Component to Patient Drug Adherence: A Qualitative-Grounded Theory Study
by: Tubbs, Jeffrey
Published: (2015)

Ethical Evaluation of Pharmaceutical Marketing in Sana’a City, Yemen
by: Gamil Q. Othman, et al.
Published: (2020-12-01)

QUANTIFICATION OF FACTORS GOVERNING DRUG RELEASE KINETICS FROM NANOPARTICLES: A COMBINED EXPERIMENTAL AND MECHANISTIC MODELING APPROACH
by: Fugit, Kyle Daniel
Published: (2014)

Access to Medicines, Access to Markets
by: Sergio Sismondo
Published: (2020-08-01)

Intellectual property and access to medicines: mapping public attitudes toward pharmaceuticals during the United States-Mexico-Canada Agreement (USMCA) negotiation process
by: Anna S. Y. Wong, et al.
Published: (2021-08-01)

Measuring brand loyalty in the pharmaceutical industry of South Africa / Hilde du Plooy
by: Du Plooy, Hilde
Published: (2013)

Measuring brand loyalty in the pharmaceutical industry of South Africa / Hilde du Plooy
by: Du Plooy, Hilde
Published: (2013)

Code of ethics for the national pharmaceutical system: Codifying and compilation
by: Pooneh Salari, et al.
Published: (2013-01-01)

Drug Import Replacement Is a Perspective Direction of the Development of Russian Economy
by: K. D. Grigorieva
Published: (2018-07-01)

DRUGS EFFICIENCY AND SAFETY: THE ROLE OF PHARMACEUTICAL INDUSTRY
by: F. I. Belyalov
Published: (2015-09-01)

Potential drug-drug interactions among hospitalized patients in a developing country
by: Sarah Mousavi, et al.
Published: (2017-07-01)

Cannot write session to /tmp/vufind_sessions/sess_m67fvsv29rismrt2scnmgos298